Bolus calculation, flexible insulin up diabetes control

February 24, 2012
Bolus calculation, flexible insulin up diabetes control

(HealthDay) -- A structured course teaching the benefits of automated bolus calculator (ABC) use and flexible intensive insulin therapy (FIIT) improves metabolic control and satisfaction in patients with type 1 diabetes, according to a study published online Feb. 16 in Diabetes Care.

Signe Schmidt, M.D., of Hvidovre University Hospital in Denmark, and associates evaluated a 16-week randomized clinical trial of 51 patients with to determine the effect of FIIT and ABC use. Eight participants were randomized to a control group; 21 to group teaching, which included FIIT and counting (CarbCount); and 22 to group teaching, which included FIIT and CarbCount using an ABC (CarbCountABC). The received FIIT education without carbohydrate counting.

The researchers found that, at 16 weeks, the within-group change in (HbA1c) was −0.1, −0.8, and −0.7 percent in the control, CarbCount, and CarbCountABC groups, respectively. There was no significant difference between the change in the CarbCount and CarbCountABC groups. The relative change in HbA1c was −0.6 and −0.8 percent in the CarbCount and CarbCountABC groups, respectively, after adjusting for baseline HbA1c (P = 0.082 and 0.017, respectively). In all the study groups there was a significant improvement in treatment satisfaction, with a significantly greater improvement found in the CarbCountABC group.

"The principles of FIIT were successfully communicated to patients in a structured three-hour course," the authors write. "In addition, the study gives indications of increased treatment satisfaction and adherence with the concurrent use of an ABC."

Several authors disclosed financial ties to Roche, which provided glucose meters and bolus calculators. Medtronic provided glucose sensors and iPro2s. The study was partially funded by Novo Nordisk.

Explore further: Structured exercise training associated with improved glycemic control for patients with diabetes

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Recommended for you

Post-biotics may help shield obese from diabetes

April 20, 2017

You've heard of pre-biotics and pro-biotics, but now you'll be hearing a lot more about post-biotics. Researchers at McMaster University have begun to identify how post-biotics, or the by-products of bacteria, lower blood ...

Diabetes continues its relentless rise

April 13, 2017

(HealthDay)—Two new studies on diabetes deliver good and bad news, but the overall message is that the blood sugar disease remains a formidable public health burden.

Researchers unravel how stevia controls blood sugar levels

April 11, 2017

What makes stevia taste so extremely sweet? And how does the sweetener keep our blood sugar level under control? Researchers at KU Leuven (University of Leuven, Belgium) have discovered that stevia stimulates a protein that ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.